The symposium offers delegates the opportunity to gain valuable insights into the Exenatide clinical trial design and explore the probabilities and early indicators of prodromal MSA. Discover how the GP2 initiative is revolutionising global genetic research and delve into the complex pathology of MSA. The afternoon session will explore emerging evidence from latest MSA clinical research trials from IONIS and Lundbeck. This event is a must for researchers, clinicians, and students eager to expand their horizons and engage in thought-provoking discussions. Don’t miss your chance to be at the forefront of medical research, innovation, and discovery!
Date: 25th April 2025
Location: UCL Great Ormand Street Institute of Child Health in London
Confirmed speakers include:
- Professor Andrew Singleton, Director of the National Institute on Aging at NIH, US
- Professor Anette Schrag, Professor of Clinical Neurosciences at UCL Clinical and Movement Neurosciences, London
- Professor Horacio Kaufmann, Professor of Neurology at NYU Langone Health, US
- Professor Tom Foltynie, Professor of Neurology at UCL National Hospital for Neurology & Neurosurgery, London
- Professor Vincenzo Libri, Professor of Translational Neurology at UCL National Hospital for Neurology & Neurosurgery, London
- Professor Wassilios Meissner, Department of Neurology for Neurodegenerative Diseases, University Hospital Bordeaux
- Professor Zane Jaunmuktane, UCL National Hospital for Neurology & Neurosurgery, London
For more information on symposium, please click HERE